Disease | down syndrome |
Comorbidity | C0014544|epilepsy |
Sentences | 10 |
PubMedID- 25894349 | epilepsy in children with down syndrome: not so benign as generally accepted. |
PubMedID- 24035599 | Objective: the prevalence of epilepsy in patients with down syndrome (ds) is 5-13%, which is higher than the prevalence in the general population. |
PubMedID- 20483713 | Improvement of myoclonic epilepsy in down syndrome treated with levetiracetam. |
PubMedID- 23992680 | Electroclinical features and long-term outcome of cryptogenic epilepsy in children with down syndrome. |
PubMedID- 21334927 | Senile myoclonic epilepsy in down syndrome. |
PubMedID- 20438626 | epilepsy occurs in 8% of individuals with down syndrome (ds). |
PubMedID- 21789369 | Taken together, these data raise the following question: is there a risk of sudden unexpected death in epilepsy in individuals with down syndrome who do not respond optimally to the treatment established by neurologists to control their seizures? |
PubMedID- 21398208 | This review discusses the various aspects of epilepsy in down syndrome (ds) from the perspective of paediatric neurology. |
PubMedID- 25661268 | Myoclonic epilepsy in down syndrome and alzheimer disease. |
PubMedID- 24893590 | Progressive myoclonus epilepsy in down syndrome patients with dementia. |
Page: 1